Total returns on $1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | BioPharma Credit PLC (Ordinary Share) | +17.65% |
| NAV | BioPharma Credit PLC (Ordinary Share) | +7.25% |
| Morningstar's Benchmark | No benchmark | -- |
- Dividend Declaration
- Notice of Full Year Results
- Net Asset Value(s) and Monthly Factsheet
- STATEMENT RE COLLEGIUM PREPAYMENT
- Net Asset Value(s) and Monthly Factsheet
- Net Asset Value(s) and Monthly Factsheet
- Director/PDMR Shareholding
- Net Asset Value(s) and Monthly Factsheet
- UPDATES ON INVESTMENT PORTFOLIO
- NEW INVESTMENT OF US$30 MILLION
More ▼
Key statistics
As of last trade BioPharma Credit PLC (BPCR:LSE) traded at 0.96, -2.02% below its 52-week high of 0.9798, set on Jun 30, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 1.13bn |
|---|---|
| Market cap | 1.04bn USD |
| Total assets | 1.16bn USD |
| Total expense ratio | -- |
| High | 0.96 |
| Low | 0.94 |
| Previous close | 0.934 |
| Average volume | 820.76k |
|---|---|
| YTD Change | +4.80% |
| Beta | 0.2237 |
| Diluted NAV (est) | 1.03 |
| Diluted NAV (last pub) | 1.02 |
| Premium/Discount | -9.08% |
| Net Gearing | 0.00% |
| Annual div (ADY) | 0.07 USD |
|---|---|
| Annual div yield (ADY) | 7.49% |
| Div ex-date | Sep 25 2025 |
| Div pay-date | Oct 31 2025 |
| Next div ex-date | Feb 19 2026 |
| Next div pay-date | Mar 20 2026 |
Data delayed at least 20 minutes, as of Feb 12 2026 15:45 GMT.
More ▼
